JMS PHARMA LTD, BELFAST, Reino Unido

Accionistas

Nombre	Participación	Voto	Desde

Beneficiario final

Nombre	Participación	País	Desde

Finanzas

Cifras clave de cuentas anuales.

Convertir a

2012

Beneficio / (pérdida): £555

Cifras clave

Beneficio / (pérdida)

2012£555

2013£-1544

2014£2198

2015£8

2016£413

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Activo total

2012£1555

2013£-544

2014£3198

2015£1008

2016£1413

2017£1115

2018£1115

2019£1115

2020£2098

2021£0

2022£1375

2023£1062

2024£12.629

2025£1095

Net Assets Liabilities

2012—

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021£0

2022£1375

2023£1062

2024£12.629

2025£1095

Equity

2012—

2013—

2014—

2015—

2016—

2017—

2018—

2019£1115

2020£2098

2021£0

2022£1375

2023£1062

2024£12.629

2025£1095

Current Assets

2012£15.506

2013£15.246

2014£24.786

2015£13.502

2016£13.047

2017£11.119

2018£13.801

2019£13.801

2020£13.041

2021£14.109

2022£44.909

2023£27.134

2024£30.863

2025£4582

Net Current Assets Liabilities

2012£627

2013£15.246

2014£1273

2015£-1858

2016£-5604

2017£-4744

2018£-2314

2019£-3448

2020£-2392

2021£-4155

2022£21.202

2023£8717

2024£11.014

2025£-14.001

Total Assets Less Current Liabilities

2012£1555

2013£16.914

2014£3198

2015£1008

2016£1413

2017£2160

2018£2249

2019£1115

2020£2098

2021£0

2022£23.875

2023£11.668

2024£18.678

2025£2862

Debtors

2012£9407

2013£10.162

2014£1848

2015£12.596

2016£1483

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Creditors

2012—

2013—

2014—

2015—

2016—

2017—

2018—

2019£17.249

2020£15.433

2021£0

2022£22.500

2023£10.606

2024£6049

2025£1767

Average Number Employees During Period

2012—

2013—

2014—

2015—

2016—

2017—

2018—

20191

20201

20212

20222

20233

20243

20252

Accruals Deferred Income

2012—

2013—

2014—

2015—

2016—

2017£1045

2018£1134

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Called Up Share Capital

2012£1000

2013£1000

2014£1000

2015£1000

2016£1000

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Cash Bank In Hand

2012£6099

2013£5084

2014£22.938

2015£906

2016£6565

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Creditors Due After One Year

2012—

2013£17.458

2014£23.513

2015—

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Creditors Due After One Year Total Noncurrent Liabilities

2012£14.879

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Creditors Due Within One Year

2012£14.879

2013£22.394

2014£23.513

2015£15.360

2016£18.651

2017£15.863

2018£16.115

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Creditors Due Within One Year Total Current Liabilities

2012£-6099

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Fixed Assets

2012£928

2013£1668

2014£1925

2015£2866

2016£7017

2017£6904

2018£4563

2019£4563

2020£4490

2021£4155

2022£2673

2023£2951

2024£7664

2025£16.863

Net Assets Liabilities Including Pension Asset Liability

2012£1555

2013£-544

2014£3198

2015£1008

2016£1413

2017£1115

2018£1115

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Profit Loss Account Reserve

2012£555

2013£-1544

2014£2198

2015£8

2016£413

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Shareholder Funds

2012£1555

2013£-544

2014£3198

2015£1008

2016£1413

2017£1115

2018£1115

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Stocks Inventory

2012—

2013—

2014—

2015£0

2016£5000

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Tangible Fixed Assets

2012£928

2013£1668

2014£1925

2015£2866

2016£7016

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Tangible Fixed Assets Additions

2012£966

2013£1581

2014£569

2015£1392

2016£7638

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Tangible Fixed Assets Cost Or Valuation

2012£966

2013£2546

2014£3115

2015£4507

2016£12.145

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Tangible Fixed Assets Depreciation

2012£38

2013£878

2014£1190

2015£1641

2016£5129

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Tangible Fixed Assets Depreciation Charged In Period

2012—

2013£840

2014£312

2015£451

2016£3488

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Tangible Fixed Assets Depreciation Charge For Period

2012£38

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Métrica	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Beneficio / (pérdida)	£555	£-1544	£2198	£8	£413	—	—	—	—	—	—	—	—	—
Activo total	£1555	£-544	£3198	£1008	£1413	£1115	£1115	£1115	£2098	£0	£1375	£1062	£12.629	£1095
Net Assets Liabilities	—	—	—	—	—	—	—	—	—	£0	£1375	£1062	£12.629	£1095
Equity	—	—	—	—	—	—	—	£1115	£2098	£0	£1375	£1062	£12.629	£1095
Current Assets	£15.506	£15.246	£24.786	£13.502	£13.047	£11.119	£13.801	£13.801	£13.041	£14.109	£44.909	£27.134	£30.863	£4582
Net Current Assets Liabilities	£627	£15.246	£1273	£-1858	£-5604	£-4744	£-2314	£-3448	£-2392	£-4155	£21.202	£8717	£11.014	£-14.001
Total Assets Less Current Liabilities	£1555	£16.914	£3198	£1008	£1413	£2160	£2249	£1115	£2098	£0	£23.875	£11.668	£18.678	£2862
Debtors	£9407	£10.162	£1848	£12.596	£1483	—	—	—	—	—	—	—	—	—
Creditors	—	—	—	—	—	—	—	£17.249	£15.433	£0	£22.500	£10.606	£6049	£1767
Average Number Employees During Period	—	—	—	—	—	—	—	1	1	2	2	3	3	2
Accruals Deferred Income	—	—	—	—	—	£1045	£1134	—	—	—	—	—	—	—
Called Up Share Capital	£1000	£1000	£1000	£1000	£1000	—	—	—	—	—	—	—	—	—
Cash Bank In Hand	£6099	£5084	£22.938	£906	£6565	—	—	—	—	—	—	—	—	—
Creditors Due After One Year	—	£17.458	£23.513	—	—	—	—	—	—	—	—	—	—	—
Creditors Due After One Year Total Noncurrent Liabilities	£14.879	—	—	—	—	—	—	—	—	—	—	—	—	—
Creditors Due Within One Year	£14.879	£22.394	£23.513	£15.360	£18.651	£15.863	£16.115	—	—	—	—	—	—	—
Creditors Due Within One Year Total Current Liabilities	£-6099	—	—	—	—	—	—	—	—	—	—	—	—	—
Fixed Assets	£928	£1668	£1925	£2866	£7017	£6904	£4563	£4563	£4490	£4155	£2673	£2951	£7664	£16.863
Net Assets Liabilities Including Pension Asset Liability	£1555	£-544	£3198	£1008	£1413	£1115	£1115	—	—	—	—	—	—	—
Profit Loss Account Reserve	£555	£-1544	£2198	£8	£413	—	—	—	—	—	—	—	—	—
Shareholder Funds	£1555	£-544	£3198	£1008	£1413	£1115	£1115	—	—	—	—	—	—	—
Stocks Inventory	—	—	—	£0	£5000	—	—	—	—	—	—	—	—	—
Tangible Fixed Assets	£928	£1668	£1925	£2866	£7016	—	—	—	—	—	—	—	—	—
Tangible Fixed Assets Additions	£966	£1581	£569	£1392	£7638	—	—	—	—	—	—	—	—	—
Tangible Fixed Assets Cost Or Valuation	£966	£2546	£3115	£4507	£12.145	—	—	—	—	—	—	—	—	—
Tangible Fixed Assets Depreciation	£38	£878	£1190	£1641	£5129	—	—	—	—	—	—	—	—	—
Tangible Fixed Assets Depreciation Charged In Period	—	£840	£312	£451	£3488	—	—	—	—	—	—	—	—	—
Tangible Fixed Assets Depreciation Charge For Period	£38	—	—	—	—	—	—	—	—	—	—	—	—	—

JMS PHARMA LTD

Resumen

Legal y estado

Línea temporal (17 eventos)

Dirección actualizada

Dirección actualizada

Empresa constituida

Red

Propiedad y gestión

Persons with significant control

Línea temporal de propiedad (2 cambios)

Nombramiento James Storey (persona)

Nombramiento Judith Storey (persona)

Accionistas

Beneficiario final

Geografía

Finanzas

Cifras clave

Documentos

Informe de la empresa JMS PHARMA LTD

Annual Accounts

Companexia Document AI

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Explorar más empresas y personas

Salud financiera

Crecimiento

Eficiencia y rentabilidad

Capital circulante y liquidez

Estructura de capital